References
- HolmanRRPaulSKBethelMAMatthewsDRNeilHA10-year follow-up of intensive glucose controlN Engl J Med20083591577158918784090
- Stamler VaccaroONeatonJDWentworthDDiabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care1993164344448432214
- HedblandBNilssonPEngstromGBerglundGJanzonLInsulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and deathDiabet Med20021947047512060058
- KurellaMLoJCChertowJMMetabolic syndrome and the risk for chronic kidney disease among nondiabetic adultsJ Am Soc Nephrol2005162134214015901764
- WelshGIHaleLJEreminaVInsulin signaling to the glomerular podocyte is critical for normal kidney functionCell Metab20101232934020889126
- PandeRLPerlsteinTSBeckmanJACreagerMAAssociation of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004Circulation2008118334118559705
- HisaoKumakuraLife prognosis of occlusive arteriosclerosis: relations among risk factors, complications and treatment methodsJ Jap Coll Angiol200242889895
- DiehmCAllenbergJRPittrowDMortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery diseaseCirculation20091202053206119901192
- SelvinEKottgenACoreshJKidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999–2002Eur Heart J2009301918192519487236
- LuoYLiXLiJPeripheral arterial disease, chronic kidney disease, and mortality: the Chinese Ankle Brachial Index Cohort StudyVasc Med20101510711220133341
- ShigematsuHNishibeTThree-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD)Int Angiol2010292 Suppl 121320357743
- NorgrenLHiattWRDormandyJAInter-Society Consensus for the Management of Peripheral Arterial Disease (TASC-II)Eur J Vasc Endovasc Surg200733Suppl 1S1S7517140820
- KawabeJUshikubiFHasebeNProstacyclin in vascular diseases: recent insights and future perspectivesCirc J20107483684320424334
- LièvreMMorandSBesseBFiessingerJNBoisselBPOral beraprost sodium, a prostaglandin I2 analogue for intermittent claudication: a double-blind randomized, multicenter controlled trialCirculation200010242643110908215
- OrigasaHIkedaYShimadaKShigematsuHOral beraprost sodium as a prostaglandin I2 analogue for vascular events in patients with peripheral arterial disease: meta-analysis of two placebo-controlled randomized trialsJpn J Pharmacoepidemiol200494551
- KubotaTKubotaNKumagaiHImpaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscleCell Metab20111329430721356519
- De BoerMPMeijerRIWijnstokNJMicrovascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertensionMicrocirculation20121951821883642
- ReavenGMInsulin resistance: the link between obesity and cardio-vascular diseaseMed Clin North Am20119587589221855697